An alternative approach to a frequently used nerve block in patients with a broken hip in the emergency department
Not Applicable
Completed
- Conditions
- Hip fractureMusculoskeletal Diseases
- Registration Number
- ISRCTN74920258
- Lead Sponsor
- Academic Medical Center
- Brief Summary
2019 results in: https://www.ncbi.nlm.nih.gov/pubmed/30770243
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 17
Inclusion Criteria
1. Adult (18 years or older) patients
2. Radiologically confirmed hip fracture
Removed 03/04/2017:
3. Will be treated with a supra-inguinal FICB in the ED
Exclusion Criteria
1. Allergies for local anesthetics
2. Polytrauma patients
3. Not receiving a supra-inguinal FICB
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umber of participants with a three-point decrease in Numerical Rating Scale (NRS) pain scores is measured prospectively for the FICB group at 30, 60 and 120 minutes after performing the nerve block and retrospectively from patient charts for those in the control group.
- Secondary Outcome Measures
Name Time Method <br> 1. Decrease in Numerical Rating Scale (NRS) pain scores for different fracture types is measured at 30, 60 and 120 minutes after administration of the FICB for the FICB group and retrospectively from patient charts for those in the control group<br> 2. Need for additional opioid analgesics is measured by emergency department and anesthesiology staff members, as well as members of the research team at 30, 60 and 120 minutes for the FICB group and retrospectively from patient charts for those in the control group<br> 3. . Occurrence of side effects is measured by emergency department and anesthesiology staff members, as well as members of the research team at 30, 60 and 120 minutes for the FICB group and retrospectively from patient charts for those in the control group<br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of opioid action in hip fracture pain management?
How does a supra-inguinal fascia iliaca block compare to systemic analgesia in reducing opioid use for hip fracture patients?
What biomarkers predict response to regional anesthesia versus systemic analgesia in geriatric hip fracture cases?
What are the potential adverse events associated with fascia iliaca compartment blocks in elderly patients with hip fractures?
What combination analgesic approaches are being explored for hip fracture management alongside nerve blocks?